QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14 作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui 收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23 breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety   Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Huang, Shuang;  Chen, Xiaozhong;  Qu, Song;  Qu, Shenhong;  Han, Yaqian 收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23 Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文 TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14 作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong 收藏  |  浏览/下载：16/0  |  提交时间：2022/01/25 Nasopharyngeal carcinoma  Metastasis  Chemotherapy  Recurrence  Anti-PD1 checkpoint inhibitor   Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma 期刊论文 MEDICINE, 2020, 卷号: 99 作者:  Wang, Fangzheng;  Jiang Chuner;  Wang Lei;  Yan Fengqin;  Ye Zhimin 收藏  |  浏览/下载：29/0  |  提交时间：2020/11/30 concurrent chemotherapy  induction chemotherapy  intensity-modulated radiotherapy  nasopharyngeal carcinoma  prognosis  toxicity   Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial 期刊论文 CHINESE MEDICAL JOURNAL, 2011, 卷号: 124 - 收藏  |  浏览/下载：1/0  |  提交时间：2020/10/26 PLUS CISPLATIN  ONCOLOGY-GROUP  CANCER  CHEMOTHERAPY  DOCETAXEL  chemotherapy  gemcitabine  cisplatin  esophageal cancer